
Clinical Trials Packaging Market Report and Forecast 2025-2034
Description
The global clinical trials packaging market attained USD 1.89 Billion in 2024. The market is projected to grow at a CAGR of 7.00% between 2025 and 2034, to attain USD 3.72 Billion by 2034.
Increasing Consumer Demand for Sustainable Packaging to Boost the Clinical Trials Packaging Industry
Due to changing regulatory requirements and growing market appetite for sustainable packaging alternatives, sustainability has remained one of the most common topics in the packaging value chain over the past decade. Consumer behavior and buying decisions, especially in the retail sector and, to some degree, in the pharmaceutical space, continue to be affected by a variety of factors. It is anticipated that growing customer affinity for sustainable packaging will remain one of the core factors likely to influence the growth of the global market for clinical trial packaging over the projected period, as a number of market participants are leaning towards the adoption of sustainable packaging materials.
Global Clinical Trials Packaging: Market Segmentation
Clinical trials are modern experiments performed to find new ways to prevent, screen for, detect, or treat illness. Such clinical trials will also illustrate which treatment methods perform well with certain disorders or groups of people. For testing purposes, clinical packaging is important, so accessibility and usability of clinical trials are of primary importance.
By material, the market is divided into:
On the basis of product, the market is divided into:
Owing to the growing need for new medicines and treatments, research and development practices within the pharmaceutical industry have changed gears in recent years, a factor that is projected to strengthen the global packaging market for clinical trials. Further, due to mounting issues about the use of plastic , the market for glass bottles is on the rise. Consistent rises in the number of cases of infectious diseases, including cancer, HIV and epilepsy, are projected to have a strong effect on the growth of the global packaging industry for clinical trials over the forecast period. The increase in the number of R&Ds, along with growing funding from governments for the production of new medicines, is projected to accelerate the growth of the global demand for clinical trials packaging during the forecast period.
Key Industry Players in the Global Clinical Trials Packaging Market
The report gives a detailed analysis of the following key players in the global clinical trials packaging market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
Increasing Consumer Demand for Sustainable Packaging to Boost the Clinical Trials Packaging Industry
Due to changing regulatory requirements and growing market appetite for sustainable packaging alternatives, sustainability has remained one of the most common topics in the packaging value chain over the past decade. Consumer behavior and buying decisions, especially in the retail sector and, to some degree, in the pharmaceutical space, continue to be affected by a variety of factors. It is anticipated that growing customer affinity for sustainable packaging will remain one of the core factors likely to influence the growth of the global market for clinical trial packaging over the projected period, as a number of market participants are leaning towards the adoption of sustainable packaging materials.
Global Clinical Trials Packaging: Market Segmentation
Clinical trials are modern experiments performed to find new ways to prevent, screen for, detect, or treat illness. Such clinical trials will also illustrate which treatment methods perform well with certain disorders or groups of people. For testing purposes, clinical packaging is important, so accessibility and usability of clinical trials are of primary importance.
By material, the market is divided into:
- Plastic
- Glass
- Metal
- Paper
- Corrugated Fibre
- Others
On the basis of product, the market is divided into:
- Vials and Ampoules
- Syringes
- Tubes
- Bottles
- Blisters
- Bags and Pouches
- Sachets
- Kits or Packs
- Others
- Research Laboratories
- Drug Manufacturing Companies
- Clinical Research Organisations
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Owing to the growing need for new medicines and treatments, research and development practices within the pharmaceutical industry have changed gears in recent years, a factor that is projected to strengthen the global packaging market for clinical trials. Further, due to mounting issues about the use of plastic , the market for glass bottles is on the rise. Consistent rises in the number of cases of infectious diseases, including cancer, HIV and epilepsy, are projected to have a strong effect on the growth of the global packaging industry for clinical trials over the forecast period. The increase in the number of R&Ds, along with growing funding from governments for the production of new medicines, is projected to accelerate the growth of the global demand for clinical trials packaging during the forecast period.
Key Industry Players in the Global Clinical Trials Packaging Market
The report gives a detailed analysis of the following key players in the global clinical trials packaging market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Bilcare Limited
- Caligor Coghlan
- Piramal Enterprises Ltd
- Corden Pharma GmbH
- WestRock Company
- Others
Table of Contents
179 Pages
- 1 Executive Summary
- 1.1 Market Size 2024-2025
- 1.2 Market Growth 2025(F)-2034(F)
- 1.3 Key Demand Drivers
- 1.4 Key Players and Competitive Structure
- 1.5 Industry Best Practices
- 1.6 Recent Trends and Developments
- 1.7 Industry Outlook
- 2 Market Overview and Stakeholder Insights
- 2.1 Market Trends
- 2.2 Key Verticals
- 2.3 Key Regions
- 2.4 Supplier Power
- 2.5 Buyer Power
- 2.6 Key Market Opportunities and Risks
- 2.7 Key Initiatives by Stakeholders
- 3 Economic Summary
- 3.1 GDP Outlook
- 3.2 GDP Per Capita Growth
- 3.3 Inflation Trends
- 3.4 Democracy Index
- 3.5 Gross Public Debt Ratios
- 3.6 Balance of Payment (BoP) Position
- 3.7 Population Outlook
- 3.8 Urbanisation Trends
- 4 Country Risk Profiles
- 4.1 Country Risk
- 4.2 Business Climate
- 5 Global Clinical Trial Packaging Market Analysis
- 5.1 Key Industry Highlights
- 5.2 Global Clinical Trial Packaging Historical Market (2018-2024)
- 5.3 Global Clinical Trial Packaging Market Forecast (2025-2034)
- 5.4 Global Clinical Trial Packaging Market by Material
- 5.4.1 Plastic
- 5.4.1.1 Historical Trend (2018-2024)
- 5.4.1.2 Forecast Trend (2025-2034)
- 5.4.1.3 Breakup by Type
- 5.4.1.3.1 Polyvinyl Chloride (PVC)
- 5.4.1.3.1.1 Historical Trend (2018-2024)
- 5.4.1.3.1.2 Forecast Trend (2025-2034)
- 5.4.1.3.2 Polyethylene (PE)
- 5.4.1.3.2.1 Historical Trend (2018-2024)
- 5.4.1.3.2.2 Forecast Trend (2025-2034)
- 5.4.1.3.2.3 Breakup by Type
- 5.4.1.3.2.3.1 High Density Polyethylene (HDPE)
- 5.4.1.3.2.3.2 Low Density Polyethylene (LDPE)
- 5.4.1.3.2.3.3 Polypropylene (PP)
- 5.4.1.3.3 Others
- 5.4.2 Glass
- 5.4.2.1 Historical Trend (2018-2024)
- 5.4.2.2 Forecast Trend (2025-2034)
- 5.4.3 Metal
- 5.4.3.1 Historical Trend (2018-2024)
- 5.4.3.2 Forecast Trend (2025-2034)
- 5.4.4 Paper
- 5.4.4.1 Historical Trend (2018-2024)
- 5.4.4.2 Forecast Trend (2025-2034)
- 5.4.5 Corrugated Fibre
- 5.4.5.1 Historical Trend (2018-2024)
- 5.4.5.2 Forecast Trend (2025-2034)
- 5.4.6 Others
- 5.5 Global Clinical Trial Packaging Market by Product
- 5.5.1 Vials and Ampoules
- 5.5.1.1 Historical Trend (2018-2024)
- 5.5.1.2 Forecast Trend (2025-2034)
- 5.5.2 Syringes
- 5.5.2.1 Historical Trend (2018-2024)
- 5.5.2.2 Forecast Trend (2025-2034)
- 5.5.3 Tubes
- 5.5.3.1 Historical Trend (2018-2024)
- 5.5.3.2 Forecast Trend (2025-2034)
- 5.5.4 Bottles
- 5.5.4.1 Historical Trend (2018-2024)
- 5.5.4.2 Forecast Trend (2025-2034)
- 5.5.5 Blisters
- 5.5.5.1 Historical Trend (2018-2024)
- 5.5.5.2 Forecast Trend (2025-2034)
- 5.5.6 Bags and Pouches
- 5.5.6.1 Historical Trend (2018-2024)
- 5.5.6.2 Forecast Trend (2025-2034)
- 5.5.7 Sachets
- 5.5.7.1 Historical Trend (2018-2024)
- 5.5.7.2 Forecast Trend (2025-2034)
- 5.5.8 Kits or Packs
- 5.5.8.1 Historical Trend (2018-2024)
- 5.5.8.2 Forecast Trend (2025-2034)
- 5.5.9 Others
- 5.6 Global Clinical Trial Packaging Market by Application
- 5.6.1 Research Laboratories
- 5.6.1.1 Historical Trend (2018-2024)
- 5.6.1.2 Forecast Trend (2025-2034)
- 5.6.2 Drug Manufacturing Companies
- 5.6.2.1 Historical Trend (2018-2024)
- 5.6.2.2 Forecast Trend (2025-2034)
- 5.6.3 Clinical Research Organisations
- 5.6.3.1 Historical Trend (2018-2024)
- 5.6.3.2 Forecast Trend (2025-2034)
- 5.7 Global Clinical Trial Packaging Market by Region
- 5.7.1 North America
- 5.7.1.1 Historical Trend (2018-2024)
- 5.7.1.2 Forecast Trend (2025-2034)
- 5.7.2 Europe
- 5.7.2.1 Historical Trend (2018-2024)
- 5.7.2.2 Forecast Trend (2025-2034)
- 5.7.3 Asia Pacific
- 5.7.3.1 Historical Trend (2018-2024)
- 5.7.3.2 Forecast Trend (2025-2034)
- 5.7.4 Latin America
- 5.7.4.1 Historical Trend (2018-2024)
- 5.7.4.2 Forecast Trend (2025-2034)
- 5.7.5 Middle East and Africa
- 5.7.5.1 Historical Trend (2018-2024)
- 5.7.5.2 Forecast Trend (2025-2034)
- 6 North America Clinical Trial Packaging Market Analysis
- 6.1 United States of America
- 6.1.1 Historical Trend (2018-2024)
- 6.1.2 Forecast Trend (2025-2034)
- 6.2 Canada
- 6.2.1 Historical Trend (2018-2024)
- 6.2.2 Forecast Trend (2025-2034)
- 7 Europe Clinical Trial Packaging Market Analysis
- 7.1 United Kingdom
- 7.1.1 Historical Trend (2018-2024)
- 7.1.2 Forecast Trend (2025-2034)
- 7.2 Germany
- 7.2.1 Historical Trend (2018-2024)
- 7.2.2 Forecast Trend (2025-2034)
- 7.3 France
- 7.3.1 Historical Trend (2018-2024)
- 7.3.2 Forecast Trend (2025-2034)
- 7.4 Italy
- 7.4.1 Historical Trend (2018-2024)
- 7.4.2 Forecast Trend (2025-2034)
- 7.5 Others
- 8 Asia Pacific Clinical Trial Packaging Market Analysis
- 8.1 China
- 8.1.1 Historical Trend (2018-2024)
- 8.1.2 Forecast Trend (2025-2034)
- 8.2 Japan
- 8.2.1 Historical Trend (2018-2024)
- 8.2.2 Forecast Trend (2025-2034)
- 8.3 India
- 8.3.1 Historical Trend (2018-2024)
- 8.3.2 Forecast Trend (2025-2034)
- 8.4 ASEAN
- 8.4.1 Historical Trend (2018-2024)
- 8.4.2 Forecast Trend (2025-2034)
- 8.5 Australia
- 8.5.1 Historical Trend (2018-2024)
- 8.5.2 Forecast Trend (2025-2034)
- 8.6 Others
- 9 Latin America Clinical Trial Packaging Market Analysis
- 9.1 Brazil
- 9.1.1 Historical Trend (2018-2024)
- 9.1.2 Forecast Trend (2025-2034)
- 9.2 Argentina
- 9.2.1 Historical Trend (2018-2024)
- 9.2.2 Forecast Trend (2025-2034)
- 9.3 Mexico
- 9.3.1 Historical Trend (2018-2024)
- 9.3.2 Forecast Trend (2025-2034)
- 9.4 Others
- 10 Middle East and Africa Clinical Trial Packaging Market Analysis
- 10.1 Saudi Arabia
- 10.1.1 Historical Trend (2018-2024)
- 10.1.2 Forecast Trend (2025-2034)
- 10.2 United Arab Emirates
- 10.2.1 Historical Trend (2018-2024)
- 10.2.2 Forecast Trend (2025-2034)
- 10.3 Nigeria
- 10.3.1 Historical Trend (2018-2024)
- 10.3.2 Forecast Trend (2025-2034)
- 10.4 South Africa
- 10.4.1 Historical Trend (2018-2024)
- 10.4.2 Forecast Trend (2025-2034)
- 10.5 Others
- 11 Market Dynamics
- 11.1 SWOT Analysis
- 11.1.1 Strengths
- 11.1.2 Weaknesses
- 11.1.3 Opportunities
- 11.1.4 Threats
- 11.2 Porter’s Five Forces Analysis
- 11.2.1 Supplier’s Power
- 11.2.2 Buyer’s Power
- 11.2.3 Threat of New Entrants
- 11.2.4 Degree of Rivalry
- 11.2.5 Threat of Substitutes
- 11.3 Key Indicators for Demand
- 11.4 Key Indicators for Price
- 12 Value Chain Analysis
- 13 Competitive Landscape
- 13.1 Supplier Selection
- 13.2 Key Global Players
- 13.3 Key Regional Players
- 13.4 Key Player Strategies
- 13.5 Company Profiles
- 13.5.1 Bilcare Limited
- 13.5.1.1 Company Overview
- 13.5.1.2 Product Portfolio
- 13.5.1.3 Demographic Reach and Achievements
- 13.5.1.4 Certifications
- 13.5.2 Caligor Coghlan
- 13.5.2.1 Company Overview
- 13.5.2.2 Product Portfolio
- 13.5.2.3 Demographic Reach and Achievements
- 13.5.2.4 Certifications
- 13.5.3 Piramal Enterprises Ltd
- 13.5.3.1 Company Overview
- 13.5.3.2 Product Portfolio
- 13.5.3.3 Demographic Reach and Achievements
- 13.5.3.4 Certifications
- 13.5.4 Corden Pharma GmbH
- 13.5.4.1 Company Overview
- 13.5.4.2 Product Portfolio
- 13.5.4.3 Demographic Reach and Achievements
- 13.5.4.4 Certifications
- 13.5.5 WestRock Company
- 13.5.5.1 Company Overview
- 13.5.5.2 Product Portfolio
- 13.5.5.3 Demographic Reach and Achievements
- 13.5.5.4 Certifications
- 13.5.6 Others
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.